Novartis AG (NVSEF)
OTCMKTS
· Delayed Price · Currency is USD
98.25
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST
Novartis AG Employees
Novartis AG had 76,057 employees as of December 31, 2023. The number of employees decreased by 25,646 or -25.22% compared to the previous year.
Employees
76,057
Change (1Y)
-25,646
Growth (1Y)
-25.22%
Revenue / Employee
$656,613
Profits / Employee
$231,445
Market Cap
206.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
Dec 31, 2019 | 103,914 | -21,247 | -16.98% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Novartis AG News
- 2 days ago - Novartis ranks first in 2024 Access to Medicine Index - GlobeNewsWire
- 3 days ago - Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer - Seeking Alpha
- 3 days ago - Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate - PRNewsWire
- 8 days ago - PPI, Novartis hold media workshop to enhance health literacy in managing cholesterol, promote heart health - BusinessMirror
- 9 days ago - Schrödinger gains on Novartis deal despite Q3 miss - Seeking Alpha
- 9 days ago - Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Benzinga
- 9 days ago - Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer - Business Wire
- 9 days ago - Schrödinger’s stock soars 9% as it enters collaboration pact with Novartis for up to about $2.5 billion in payments - MarketWatch